Muscarinic agonists for the treatment of Alzheimer's disease: progress and perspectives (Q51990804)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published in October 1997

Language	Label	Description	Also known as
English	Muscarinic agonists for the treatment of Alzheimer's disease: progress and perspectives	scientific article published in October 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15989509

Muscarinic agonists for the treatment of Alzheimer's disease: progress and perspectives (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15989509

Alzheimer's disease

1 reference

based on heuristic

inferred from title

author name string

Fisher A

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15989509

language of work or name

0 references

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15989509

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15989509

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15989509

10

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15989509

1395-1411

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15989509

Dementia: the neurochemical basis of putative transmitter orientated therapy

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Alzheimer's disease: specific increases in a G protein subunit (GSα) mRNA in hippocampal and cortical neurons

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Muscarinic receptor subtypes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

L-687,306: a functionally selective and potent muscarinic M1 receptor agonist

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Muscarinic activity of the thiolactone, lactam, lactol, and thiolactol analogues of pilocarpine and a hypothetical model for the binding of agonists to the m1 receptor

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

WAL 2014--a muscarinic agonist with preferential neuron-stimulating properties

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Muscarinic control of amyloid precursor protein secretion in rat cerebral cortex and cerebellum

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Muscarinic agonists in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

AF150(S): A new functionally selective M1 agonist improves cognitive performance in rats

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

AF102B, a novel M1 agonist, enhanced spatial learning in C57BL/10 mice with a long duration of action

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Preclinical and phase 1 clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Induction of depression with oxotremorine in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1395

21 January 2018

Identifiers

10.1517/13543784.6.10.1395

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15989509

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15989509

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51990804&oldid=2287074658"